Arno Therapeutics Inc ARNI
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- — / —
- Shares Outstanding
- 49.35M
- Market Cap
- $4,984.32
- Volume/Avg
- 4,580 / 4,540
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage products under the following names: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate, and breast cancer indications; AR-42 is provided for hematological malignancies and solid tumor indications; and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 4
- Website
- https://www.arnothera.com
Valuation
|
Metric
|
ARNI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ARNI
|
|---|---|
Quick Ratio | 1.39 |
Current Ratio | 1.52 |
Interest Coverage | −323.28 |
Quick Ratio
No chart available
Profitability
|
Metric
|
ARNI
|
|---|---|
Return on Assets (Normalized) | −708.63% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|^NK?SH | LOCK|<%&n | $126B | |||
| Moderna Inc
MRNA
| LOCK|>FNVPD$ | LOCK|xM? | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|<q&dMw | LOCK|^PMcV | $80B | |||
| argenx SE ADR
ARGX
| LOCK|<@yKY!@ | LOCK|@L# | $53B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|^d<QY> | LOCK|Ms> | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|njLpc?s | LOCK|&@B! | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|Vj@&!lxP | LOCK|#WQ< | $26B | |||
| Incyte Corp
INCY
| LOCK|Y?N%Z&B | LOCK|hc% | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|Lv#b## | LOCK|^QF | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|N&^MrK | LOCK|DW^ | $14B |
United States